Across TCGA pan-cancer cohorts, FAM102A RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM102A data layer compared with 4 for mutation status and 3 for mass-spec protein.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FAM102A RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated FAM102A expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.
HNSC, ACC, and COAD are the cancer types where FAM102A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.